{"id":59344,"date":"2024-05-09T22:03:24","date_gmt":"2024-05-09T20:03:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/"},"modified":"2024-05-09T22:03:24","modified_gmt":"2024-05-09T20:03:24","slug":"mindmed-to-participate-at-may-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/","title":{"rendered":"MindMed to Participate at May Investor Conferences"},"content":{"rendered":"<div>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24MNMD&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$MNMD<\/a>&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company\u2019s management team will participate in the following investor conferences:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/5\/MNMD_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/5\/MNMD_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/21\/MNMD_Logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>2024 RBCCM Global Healthcare Conference<\/b><\/p>\n<ul class=\"bwlistcircle\">\n<li>\nFormat: Fireside Chat<\/li>\n<li>\nDate and Time: Wednesday, May 15, 2024 at 11:00 am EDT<\/li>\n<li>\nLocation: New York, NY<\/li>\n<li>\nWebcast Link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.veracast.com%2Fwebcasts%2Frbc%2Fhealthcare2024%2F9i46C0.cfm&amp;esheet=53983274&amp;newsitemid=20240509762996&amp;lan=en-US&amp;anchor=2024+RBCCM+Global+Healthcare+Conference&amp;index=1&amp;md5=9ab2d194db103caf6cefceefe9b0ca10\" rel=\"nofollow noopener\" shape=\"rect\">2024 RBCCM Global Healthcare Conference<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>HCW&#8217;s 2nd Annual BioConnect Investor Conference<\/b><\/p>\n<ul class=\"bwlistcircle\">\n<li>\nFormat: 1&#215;1 investor meetings only<\/li>\n<li>\nDate: May 20, 2024<\/li>\n<li>\nLocation: New York, NY<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nAn audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference will be accessible on MindMed\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmindmed.co%2Finvestor-resources%2F&amp;esheet=53983274&amp;newsitemid=20240509762996&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=2&amp;md5=de4b598bf31e87be752c928c7e9e0c83\" rel=\"nofollow noopener\" shape=\"rect\">Investor Relations<\/a> website for up to 90 days following the event.<\/p>\n<p>\n<b>About MindMed<\/b><\/p>\n<p>\nMindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For Media:<\/b> <a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#109;&#x65;&#x64;i&#97;&#x40;m&#105;&#x6e;&#x64;m&#101;&#x64;&#46;&#99;&#x6f;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x65;&#100;&#x69;&#97;&#x40;m&#x69;n&#100;&#x6d;&#101;&#x64;&#46;&#x63;o<\/a><br \/><b>For Investors:<\/b> <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#105;&#114;&#64;&#x6d;&#x69;&#110;&#100;m&#x65;&#x64;&#x2e;&#99;o\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x72;&#64;m&#x69;&#x6e;&#x64;&#109;e&#x64;&#x2e;&#x63;&#111;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company\u2019s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59344","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindMed to Participate at May Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMed to Participate at May Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company\u2019s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-09T20:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MindMed to Participate at May Investor Conferences\",\"datePublished\":\"2024-05-09T20:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/\"},\"wordCount\":213,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240509762996\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/\",\"name\":\"MindMed to Participate at May Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240509762996\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"datePublished\":\"2024-05-09T20:03:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240509762996\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240509762996\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-participate-at-may-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMed to Participate at May Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMed to Participate at May Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"MindMed to Participate at May Investor Conferences - Pharma Trend","og_description":"NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company\u2019s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2024-05-09T20:03:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MindMed to Participate at May Investor Conferences","datePublished":"2024-05-09T20:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/"},"wordCount":213,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/","name":"MindMed to Participate at May Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg","datePublished":"2024-05-09T20:03:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240509762996\/en\/2047733\/22\/MNMD_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-participate-at-may-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MindMed to Participate at May Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59344"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59344\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}